Quarterly ResultApr 30, 2026, 04:20 PM
RMD Q3 Revenue +11% to $1.4B; Non-GAAP EPS $2.86; Dividend $0.60
AI Summary
ResMed Inc. announced strong results for Q3 FY2026, with revenue increasing 11% to $1.4 billion and non-GAAP diluted EPS rising 21% to $2.86. The company reported significant gross margin expansion and increased income from operations, driven by demand for sleep devices and masks. Additionally, the board declared a quarterly cash dividend of $0.60 per share, payable on June 18, 2026.
Key Highlights
- Revenue increased 11% to $1.43 billion (8% constant currency) for Q3 FY2026.
- Non-GAAP diluted EPS rose 21% to $2.86; GAAP diluted EPS increased 10% to $2.74.
- Non-GAAP gross margin expanded by 290 basis points to 62.8%.
- Non-GAAP income from operations grew 18% to $524.8 million.
- Operating cash flow was $554 million; $262 million returned to shareholders.
- Board declared a quarterly cash dividend of $0.60 per share, payable June 18, 2026.
- U.S., Canada, and Latin America revenue (excl. software) grew 9% constant currency.
- Europe, Asia, and other markets revenue (excl. software) grew 7% constant currency.